Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy

Abstract Background The aim of this study was to investigate the efficacy of bevacizumab (Bev) in reducing peritumoral brain edema (PTBE) after stereotactic radiotherapy (SRT) for lung cancer brain metastases. Methods A retrospective analysis was conducted on 44 patients with lung cancer brain metas...

Full description

Bibliographic Details
Main Authors: Yi‐Chun Hua, De‐Zhi Gao, Kuan‐Yu Wang, Xiao‐Sheng Ding, Wei‐Ran Xu, Yu‐Bin Li, Wei‐Wei Shi, Shi‐Bin Sun, Xiao‐Yan Li
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Thoracic Cancer
Subjects:
bevacizumab
brain metastases
lung cancer
peritumoral brain edema
radiotherapy
Online Access:https://doi.org/10.1111/1759-7714.15106

Similar Items

Similar Items